Angiogenesis in the latissimus dorsi muscle using different regimens of electrical stimulation and pharmaceutical support

被引:3
作者
Chekanov, VS [1 ]
Maternowski, MA [1 ]
Eisenstein, R [1 ]
Hernandez, I [1 ]
Nikolaychik, VV [1 ]
机构
[1] Sinai Samaritan Med Ctr, Milwaukee Heart Inst, Milwaukee, WI USA
关键词
D O I
10.1097/00002480-200005000-00013
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
It is our contention that the prevention of ischemia-reperfusion injuries immediately after latissimus dorsi muscle (LDM) mobilization and enhancement of angiogenesis will be effective in improving cardiomyoplasty results. The investigations were performed on adult sheep. Three hours after LDM mobilization, various stages of leukocyte-endothelium interaction were revealed: leukocytes binding to the endothelium, leukocyte destruction of endothelium, and leukocytes leaving capillaries through gaps in the endothelium. Fifty-six days after mobilization various stages of necrosis were discernible. The area occupied by capillaries was 3.45 +/- 0.26% vs. 3.99 +/- 0.24% in control muscle; most of the endothelial cells exhibited morphologic degeneration. Electrical stimulation with 60 CPM actually decreased the capillary density to 2.15 +/- 0.7%, and most of the endothelial cells were damaged, with disrupted plasma membranes. Muscle subjected to 15 CPM increased the percent of capillaries to 5.01 +/- 0.56%, and endothelial cells appeared normal in ultrastructure. Pharmaceutical support prevented muscle damage and accelerated revascularization. After 56 days of autologous biological glue (ABG) application, the area occupied by capillaries was 5.57 +/- 0.24%. This increased to 8.47 +/- 0.72% when aprotinin (proteinase inhibitor) was added to ABG, and to 9.40 +/- 1.24% with pyrrolostatin (free radical scavenger). Both ABC application with aprotinin and electrical stimulation at 15 CPM prevent the LDM from postmobilization damage, and increase angiogenic potential.
引用
收藏
页码:305 / 312
页数:8
相关论文
共 43 条
[1]   GIRDLING EFFECT OF NONSTIMULATED CARDIOMYOPLASTY ON LEFT-VENTRICULAR FUNCTION [J].
CAPOUYA, ER ;
GERBER, RS ;
DRINKWATER, DC ;
PEARL, JM ;
SACK, JB ;
AHARON, AS ;
BARTHEL, SW ;
KACZER, EM ;
CHANG, PA ;
LAKS, H ;
LIAO, KX ;
SINK, JD .
ANNALS OF THORACIC SURGERY, 1993, 56 (04) :867-871
[2]  
CARPENTIER A, 1985, LANCET, V1, P1267
[3]   APROTININ VERSUS DESMOPRESSIN FOR PATIENTS UNDERGOING OPERATIONS WITH CARDIOPULMONARY BYPASS - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY [J].
CASAS, JI ;
ZUAZUJAUSORO, I ;
MATEO, J ;
OLIVER, A ;
LITVAN, H ;
MUNIZDIAZ, E ;
ARIS, A ;
CARALPS, JM ;
FONTCUBERTA, J .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1995, 110 (04) :1107-1117
[4]   THE SCIENTIFIC DEVELOPMENT OF DYNAMIC CARDIOMYOPLASTY [J].
CHACHQUES, JC ;
CARPENTIER, AF .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1995, 110 (04) :1154-1155
[5]   Biologic clue increases capillary ingrowth after cardiomyoplasty in an ischemic cardiomyopathy model [J].
Chekanov, VS ;
Tchekanov, GV ;
Rieder, MA ;
Eisenstein, R ;
Wankowski, DM ;
Schmidt, DH ;
Nikolaychik, VV ;
Lelkes, PI .
ASAIO JOURNAL, 1996, 42 (05) :M480-M487
[6]  
Chekanov VS, 1998, BASIC APPL MYOL, V8, P211
[7]  
Chekanov VS, 1998, BASIC APPL MYOL, V8, P27
[8]   Comparison of different regimens of electrical stimulation applied to nonmobilized and newly mobilized latissimus dorsi muscle [J].
Chekanov, VS ;
Rieder, MA ;
Tchekanov, GV ;
Smith, LM ;
Eisenstein, R ;
Schmidt, DH .
JOURNAL OF CARDIAC SURGERY, 1997, 12 (05) :343-353
[9]  
Chekanov VS, 1997, BAKKEN RES, V11, P115
[10]  
CHEKANOV VS, 1996, ANN THORAC SURG, V4, P1245